HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B

Liver

Volumn 19, Issue 4, 1999, Pages 294-298

  Lindh, Magnus ^a,c   Savage, Kay ^b   Rees, Julia ^b   Garwood, Linda ^b   Horal, Peter ^a   Norkrans, Gunnar ^a   Dhillon, Amar P ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c Dept of Clinical Virology ^*  (Sweden)

Author keywords

Antigen; HBV; Histology activity index; Liver biopsy; Mutation; Viral load

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOPLASM; DEVICE; DISEASE COURSE; FEMALE; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER INJURY; MALE; SERUM; VIRUS CARRIER; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIOPSY; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; VIRAL LOAD;

EID: 0032788250     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00052.x     Document Type: Article

References (24)

1. PETERS M, VIERLING J, GERSHWIN M E, MILICH D, CHISARI F V, HOOFNAGLE J H. Immunology and the liver. Hepatology 1991; 13: 977-94.
2. MILICH D R, JONES J E, HUGHES J L, PRICE J, RANEY A K, MCLACHLAN A. Is a function of the secreted HBeAg to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-603.
3. FERRARI C, PENNA A, BERTOLETTI A, FIACCADORI F. Cell mediated immune response to hepatitis B virus nucleocapsid antigen. Arch Virol 1993; 8: S91-101.
4. MARUYAMA T, MCLACHLAN A, IINO S, KOIKE K. KUROKAWA K, MILICH D R. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993; 91: 2586-95.
5. CARMAN W, JACYNA M R, HADZIYANNIS S, et al. Mutation preventing formation of HBeAg in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-91.
6. LINDH M, HORAL P, DHILLON A P, FURUTA Y, NORKRANS G. Hepatitis B virus carriers without precore mutations in HBeAg-negative stage show more severe liver damage. Hepatology 1996; 24: 494-501.
7. LINDH M, ANDERSSON A S, GUSDAL A. Genotypes, nt 1858 variants and geographic origin of hepatitis B virus - large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-93.
8. LINDH M, GONZALEZ J E, NORKRANS G, HORAL P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods 1998; 72: 163-74.
9. KNODELL R G, ISHAK K G, BLACK WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
10. REALDI G, ALBERTI A, RUGGE M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195-9.
11. LINDH M, FURUTA Y, VAHLNE A, NORKRANS G, HORAL P. Emergence of precore TAG stopcodon mutation during hepatitis B e seroconversion and its dependence on the pregenomic basepairing between nucleotides 1858 and 1896. J Infect Dis 1995; 172: 1343-7.
12. MARUYAMA T, KUWATA S, KOIKE K, et al. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion. Hepatology 1998; 27: 245-53.
13. CASTILLO I, BARTOLOMÉ J, QUIROGA J A, PORRES J C, CARRENO V. Detection of HBeAg/anti-HBe immune complexes in the reactivation of hepatitis B virus replication among anti-HBe chronic carriers. Liver 1990; 10: 79-84.
14. MORIYAMA K, OKAMOTO H, TSUDA F, MAYUMI M. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 1996; 226: 269-80.
15. BUCKWOLD V, XU Z, CHEN M, YEN S B, OU J. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70: 5845-51.
16. HADZIYANNIS S J, LIEBERMAN H M, KARVOUNTZIS G G, SHAFRITZ D A. Analysis of liver disease, nuclear HBcAg, viral replication, and HBV DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 1983; 3: 656-62.
17. HSU H C, SU I J, LAI M Y, et al. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol 1987; 5: 45-50.
18. OMATA M, YOKOSUKA O, IMAZEKI F. et al. Correlation of hepatitis B virus DNA and antigens in the liver. A study in chronic liver disease. Gastroenterology 1987; 92: 192-6.
19. GUIDOTTI L G, ANDO K, HOBBS M V, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994; 91: 3764-8.
20. ROMERO R, LAVINE J E. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23: 17-23.
21. GRAY A H, FANG J W, DAVIS G L, et al. Variations of hepatitis B virus core gene sequence in Western patients with chronic hepatitis B virus infection. J Viral Hepat 1997; 4: 371-8.
22. NAOUMOV N V, SCHNEIDER R, GROTZINGER T, et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992; 102: 538-43.
23. VILLARI D, POLLICINO T, SPINELLA S, et al. Hepatitis B E antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. Am J Clin Pathol 1995; 103: 136-40.
24. DIENES H P, GERKEN G, GOERGEN B, HEERMANN K, GERLICH W, MEYER ZUM BUSCHENFELDE K H. Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis B e-positive chronic hepatitis. Hepatology 1995; 21: 1-7.